Literature DB >> 17114369

Emphysema in COPD: consequences and causes.

G M Turino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114369      PMCID： PMC2117054          DOI： 10.1136/thx.2006.066308

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  20 in total

Review 1.  Cellular and structural bases of chronic obstructive pulmonary disease.

Authors:  M Saetta; G Turato; P Maestrelli; C E Mapp; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

3.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease.

Authors:  Leonardo M Fabbri; Micaela Romagnoli; Lorenzo Corbetta; Gianluca Casoni; Kamelija Busljetic; Graziella Turato; Guido Ligabue; Adalberto Ciaccia; Marina Saetta; Alberto Papi
Journal:  Am J Respir Crit Care Med       Date:  2002-11-08       Impact factor: 21.405

4.  Association between markers of emphysema and more severe chronic obstructive pulmonary disease.

Authors:  P Boschetto; S Quintavalle; E Zeni; S Leprotti; A Potena; L Ballerin; A Papi; G Palladini; M Luisetti; L Annovazzi; P Iadarola; E De Rosa; L M Fabbri; C E Mapp
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

5.  Predominant emphysema phenotype in chronic obstructive pulmonary.

Authors:  P Boschetto; M Miniati; D Miotto; F Braccioni; E De Rosa; I Bononi; A Papi; M Saetta; L M Fabbri; C E Mapp
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

6.  Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  C E Brightling; W Monteiro; R Ward; D Parker; M D Morgan; A J Wardlaw; I D Pavord
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

Review 7.  Proteinases in chronic obstructive pulmonary disease.

Authors:  S D Shapiro
Journal:  Biochem Soc Trans       Date:  2002-04       Impact factor: 5.407

8.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

9.  Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease.

Authors:  R E Louis; D Cataldo; M G Buckley; J Sele; M Henket; L C Lau; P Bartsch; A F Walls; R Djukanovic
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

Review 10.  Chronic obstructive pulmonary disease: molecular and cellular mechanisms.

Authors:  P J Barnes; S D Shapiro; R A Pauwels
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.